John S Munday Selected Research

John S Munday Research Topics

Disease

20	Neoplasms (Cancer) 01/2023 - 05/2003
17	Infections 09/2023 - 04/2011
9	Papilloma (Papillomatosis) 04/2024 - 09/2007
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2022 - 06/2010
5	Carcinoma (Carcinomatosis) 09/2020 - 08/2013
3	Neoplasm Metastasis (Metastasis) 12/2020 - 05/2020
3	Urinary Bladder Neoplasms (Bladder Cancer) 02/2019 - 03/2008
2	Sarcoma (Soft Tissue Sarcoma) 03/2023 - 12/2011
2	Vitamin A Deficiency 05/2022 - 11/2009
2	Pyelonephritis 05/2022 - 11/2009
2	Hypoxia (Hypoxemia) 09/2021 - 09/2019
2	Skin Neoplasms (Skin Cancer) 03/2018 - 09/2016
2	Inflammation (Inflammations) 01/2017 - 12/2011
2	Crohn Disease (Crohn's Disease) 01/2017 - 01/2013
2	Colitis 01/2017 - 01/2013
2	Autoimmune Lymphoproliferative Syndrome 01/2017 - 01/2017
2	Hemolytic Anemia 12/2005 - 05/2003
2	Hypertension (High Blood Pressure) 07/2004 - 06/2002
2	Renal Insufficiency (Renal Failure) 07/2004 - 06/2002
1	Basal Cell Carcinoma (Rodent Ulcer) 09/2023
1	Shellfish Poisoning 01/2023
1	Azotemia 08/2022
1	Hypotension (Low Blood Pressure) 08/2022
1	Metaplasia 05/2022
1	Hemangiosarcoma (Angiosarcoma) 05/2020
1	Lymphoma (Lymphomas) 01/2020
1	Hepatitis 10/2019
1	Reinfection 07/2019
1	Feline Infectious Peritonitis 01/2019
1	Body Weight (Weight, Body) 01/2017
1	Hyperplasia 06/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2013
1	Actinic Keratosis 08/2011
1	Squamous Cell Carcinoma of Head and Neck 04/2011
1	Skin Diseases (Skin Disease) 08/2010
1	Dermatitis 08/2010
1	Cystitis 11/2009
1	Nephrolithiasis 11/2009
1	Urolithiasis 11/2009

Drug/Important Bio-Agent (IBA)

24	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 09/2007
12	Proteins (Proteins, Gene)FDA Link 09/2023 - 06/2002
5	VaccinesIBA 09/2021 - 12/2011
5	Oncogene Proteins (Oncogene Protein)IBA 04/2020 - 07/2016
4	EnzymesIBA 08/2022 - 05/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2023 - 09/2019
2	A-Form DNA (A-DNA)IBA 09/2022 - 04/2021
2	Meloxicam (Mobic)FDA LinkGeneric 08/2022 - 12/2011
2	Vitamin A (Retinol)FDA LinkGeneric 05/2022 - 11/2009
2	Formaldehyde (Formol)FDA Link 01/2019 - 01/2016
2	ParaffinIBA 01/2019 - 01/2016
2	Fas Ligand Protein (Fas Ligand)IBA 01/2017 - 01/2017
2	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2008 - 05/2003
2	Sulfides (Thioethers)IBA 12/2005 - 05/2003
1	Angiogenic ProteinsIBA 03/2023
1	DecorinIBA 03/2023
1	ptaquilosideIBA 01/2023
1	Tetrodotoxin (Tetradotoxin)IBA 01/2023
1	Atenolol (Tenormin)FDA LinkGeneric 08/2022
1	benazepril (Briem)FDA LinkGeneric 08/2022
1	CurcuminIBA 08/2022
1	Metformin (Glucophage)FDA LinkGeneric 08/2022
1	Keratins (Keratin)IBA 03/2022
1	Retinoblastoma ProteinIBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2021
1	B7-H1 AntigenIBA 12/2020
1	LigandsIBA 12/2020
1	Imiquimod (Aldara)FDA LinkGeneric 10/2020
1	Chemokine ReceptorsIBA 09/2020
1	ChemokinesIBA 09/2020
1	Thalidomide (Thalomid)FDA Link 05/2020
1	Temazepam (Nocturne)FDA LinkGeneric 01/2020
1	Nucleic AcidsIBA 10/2019
1	Oxygen (Dioxygen)IBA 09/2019
1	Neutralizing AntibodiesIBA 07/2019
1	PolyproteinsIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	InterferonsIBA 06/2018
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 06/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 06/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Viral DNAIBA 01/2018
1	CytokinesIBA 01/2017
1	Interleukin-12 (IL 12)IBA 01/2017
1	Monocyte Chemoattractant ProteinsIBA 01/2017
1	InterleukinsIBA 01/2017
1	Dextrans (Dextran)FDA Link 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017
1	Peroxidase (Myeloperoxidase)IBA 01/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2011
1	Cyclin-Dependent Kinase Inhibitor p16IBA 08/2011
1	PowdersIBA 11/2009
1	AlbuminsIBA 11/2009

Therapy/Procedure

4	Therapeutics 12/2020 - 04/2006
1	Conservative Treatment 12/2020
1	Lasers (Laser) 10/2016
1	Euthanasia (Mercy Killing) 09/2016
1	Enteral Nutrition (Feeding, Tube) 01/2013
1	Injections 12/2011